Request a Consultation
Our experts can help you reframe what’s possible.
A large pharmaceutical manufacturer sought to evaluate how its specialty pharmacy portfolio could align with emerging direct-to-employer (DTE) models. The organization wanted to better understand the evolving DTE landscape, identify partnership opportunities, assess employer expectations, and determine the operational requirements necessary for successful implementation.
The goal was to evaluate opportunities to improve gross-to-net (GTN) performance while developing a scalable strategy for engaging employers through innovative contracting and service models.
Acumetis conducted a comprehensive assessment of the DTE ecosystem to understand stakeholder expectations, partnership opportunities, and implementation considerations.
This included:
Leveraging our network:
Building the strategy:
Insights were synthesized into a strategic framework focused on product fit, pricing considerations, GTN improvement opportunities, contracting strategy, and deployment planning.
Through this engagement, the client gained a clearer understanding of the evolving direct-to-employer (DTE) landscape, including the stakeholders, partnership models, and market dynamics shaping future opportunities. By engaging with key players across the ecosystem, the organization was able to identify potential partnership opportunities and better understand the capabilities required to support a successful DTE strategy.
The engagement also resulted in a detailed playbook and strategic roadmap designed to guide future decision-making. The roadmap provided a structured framework for evaluating assets, assessing potential partners, and planning a phased deployment approach with vendors and employers. These insights helped position the client to evaluate DTE opportunities more strategically while creating a practical path toward future implementation.
Successfully evaluating emerging commercialization models requires a deep understanding of stakeholder priorities, market dynamics, and operational realities.
By engaging organizations across the DTE ecosystem and translating those perspectives into actionable recommendations, the client gained the clarity needed to evaluate opportunities, reduce uncertainty, and make more informed strategic decisions.
Commercial success requires connected thinking across brand, asset, portfolio, and enterprise priorities. We combine competitive intelligence, customer insights, market dynamics, and commercial expertise to help organizations make confident decisions from asset evaluation and portfolio strategy through launch and in-market optimization. Drawing on experience across 200+ launches, we help clients challenge assumptions, align stakeholders, and turn strategy into execution.
Acumetis helps pharmaceutical manufacturers assess emerging commercialization models, identify strategic opportunities, and develop actionable roadmaps that support growth, market access, and long-term success.
Our experts can help you reframe what’s possible.
"*" indicates required fields